0001493152-24-013225.txt : 20240404
0001493152-24-013225.hdr.sgml : 20240404
20240404171810
ACCESSION NUMBER: 0001493152-24-013225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240401
FILED AS OF DATE: 20240404
DATE AS OF CHANGE: 20240404
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bailey Gregory
CENTRAL INDEX KEY: 0001329505
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 24823985
MAIL ADDRESS:
STREET 1: 4 A CHESHAM STREET
CITY: LONDON
STATE: X0
ZIP: SW1X8DT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Serina Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 821436829
STATE OF INCORPORATION: AL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
BUSINESS PHONE: (256) 327-9630
MAIL ADDRESS:
STREET 1: 601 GENOME WAY
STREET 2: SUITE 2001
CITY: HUNTSVILLE
STATE: AL
ZIP: 35806
FORMER COMPANY:
FORMER CONFORMED NAME: AgeX Therapeutics, Inc.
DATE OF NAME CHANGE: 20170606
4
1
ownership.xml
X0508
4
2024-04-01
0
0001708599
Serina Therapeutics, Inc.
SER
0001329505
Bailey Gregory
601 GENOME WAY, SUITE 2001
HUNTSVILLE
AL
35806
1
0
0
0
0
Stock Option (right to buy)
11.828
2024-04-01
4
A
0
40000
0
A
2034-04-01
Common Stock
40000
44691
D
The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
Number of derivative securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.
/s/ Gregory Bailey
2024-04-04